Ningbo MedicalSystem Biotechnology Co Ltd (300439) — Strategic Asset Allocation Index
Ningbo MedicalSystem Biotechnology Co Ltd (300439) has a Strategic Asset Allocation Index of 42.3% as of December 2022. Strategic assets (PP&E of CN¥1.07 Billion plus long-term investments of CN¥-) total CN¥1.07 Billion, measured against net assets of CN¥2.52 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Ningbo MedicalSystem Biotechnology Co Ltd Strategic Asset Allocation Index (2012–2022)
This chart shows how Ningbo MedicalSystem Biotechnology Co Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2012 to 2022. As of December 2022, the index stands at 42.3%, representing strategic assets of CN¥1.07 Billion against net assets of CN¥2.52 Billion CNY. Explore 300439 cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Ningbo MedicalSystem Biotechnology Co Ltd (2012–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Ningbo MedicalSystem Biotechnology Co Ltd from 2012 to 2022, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 300439 company net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 42.3% | CN¥1.07 Billion | CN¥1.07 Billion | CN¥- | CN¥2.52 Billion | ▼ -1.6 pp |
| 2021 | 43.9% | CN¥1.05 Billion | CN¥1.05 Billion | CN¥- | CN¥2.39 Billion | ▼ -18.1 pp |
| 2020 | 62.0% | CN¥1.05 Billion | CN¥1.05 Billion | CN¥- | CN¥1.69 Billion | ▼ -3.3 pp |
| 2019 | 65.3% | CN¥906.21 Million | CN¥906.21 Million | CN¥- | CN¥1.39 Billion | ▲ +21.2 pp |
| 2018 | 44.1% | CN¥1.00 Billion | CN¥721.95 Million | CN¥278.06 Million | CN¥2.27 Billion | ▲ +12.7 pp |
| 2017 | 31.3% | CN¥716.12 Million | CN¥521.80 Million | CN¥194.32 Million | CN¥2.29 Billion | ▲ +1.6 pp |
| 2016 | 29.7% | CN¥543.25 Million | CN¥265.34 Million | CN¥277.91 Million | CN¥1.83 Billion | ▲ +15.7 pp |
| 2015 | 14.0% | CN¥180.56 Million | CN¥180.56 Million | CN¥- | CN¥1.29 Billion | ▼ -21.0 pp |
| 2014 | 35.0% | CN¥145.44 Million | CN¥145.44 Million | CN¥- | CN¥415.13 Million | ▼ -2.0 pp |
| 2013 | 37.1% | CN¥114.29 Million | CN¥114.29 Million | CN¥- | CN¥308.32 Million | ▼ -8.8 pp |
| 2012 | 45.9% | CN¥92.99 Million | CN¥92.99 Million | CN¥- | CN¥202.58 Million | — |